- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06330168
Paravertebral Calcitonin in Thoracotomy
The Analgesic Value of Paravertebral Calcitonin in Patients Undergoing Thoracotomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Single-shot thoracic paravertebral block combined with intravenous analgesia is one of the regional techniques used for controlling pain in patients undergoing thoracic surgery. However, few articles demonstrated its effects on acute pain and chronic pain after thoracotomy and revealed high postoperative opioid consumption and inability to reduce the incidence of chronic pain.
Calcitonin has previously been shown to be effective in the management of acute pain following amputation, vertebral fractures and other neuropathic conditions.
Using calcitonin as an additive in thoracic paravertebral block was not evaluated in previous studies, we conducted this study as we hypothesize that calcitonin use as an additive in thoracic paravertebral block for patients undergoing thoracotomy may have extended analgesic effects regarding decreasing postoperative pain scores, opioid consumption, and this value may decrease the incidence of chronic post-thoracotomy pain.
In both groups, ultrasound-guided thoracic paravertebral block will be performed before anesthetic induction using a high-frequency linear probe after identifying the paravertebral space of the proposed level of intercostal skin incision.General anesthesia in both groups will be similar.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Osama M Rehab, MD
- Phone Number: 01095210806
- Email: osamarehab@med.tanta.edu.eg
Study Locations
-
-
Gharbiya
-
Tanta, Gharbiya, Egypt, 31527
- Recruiting
- Tanta University Hospitals
-
Contact:
- Osama M Rehab, MD
- Phone Number: 01095210806
- Email: osamarehab@med.tanta.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged ≥ 18 years
- American society of anesthesiology (ASA) physical status of I-III
- scheduled for elective thoracotomy
Exclusion Criteria:
- Contraindication to thoracic paravertebral block as coagulopathy or local anesthetic allergy.
- Pregnancy
- History of cardiovascular and gastro-esophageal surgery
- Preexisting pain syndrome or psychological disorders
- Severe hepatic, cardiovascular, or renal disorders
- Allergy to calcitonin
- Patients who will be re-operated and who will report infections
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: bupivacaine-calcitonin-fentanyl group
thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 100 IU of calcitonin (1ml)
|
pre-induction single shot thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 100 IU of calcitonin (1ml).
|
Placebo Comparator: bupivacaine-fentanyl group
thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 1 ml saline 0.9%.
|
pre-induction single shot thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 1 ml saline 0.9%.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
morphine consumption
Time Frame: from the end of surgery until the end of the first postoperative day
|
total morphine consumption in the first 24 hours after surgery
|
from the end of surgery until the end of the first postoperative day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Side effects
Time Frame: first postoperative day
|
hypotension, postoperative nausea and vomiting
|
first postoperative day
|
numerical rating scale scores
Time Frame: from arrival to the post-anesthesia care unit until 48 hour after surgery.
|
A 0-10 cm numerical rating scale ( 0 means no pain and 10 means the worst pain) at coughing and at rest will be assessed by an investigator during the first and second day post operation
|
from arrival to the post-anesthesia care unit until 48 hour after surgery.
|
incidence of chronic pain
Time Frame: 3 months and 6 months after surgery
|
chronic pain at 3 and 6 months after surgery
|
3 months and 6 months after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Vasodilator Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Anesthetics, Local
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Fentanyl
- Bupivacaine
- Calcitonin
- Salmon calcitonin
- Calcitonin Gene-Related Peptide
- Katacalcin
Other Study ID Numbers
- 36264PR573/2/24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracotomy
-
University of Maryland, BaltimoreAtriCure, Inc.RecruitingChronic Post-thoracotomy Pain | Post-thoracotomy Pain Syndrome | Acute Post-thoracotomy PainUnited States
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Yuzuncu Yıl UniversityUnknown
-
Yeungnam University College of MedicineUnknownThoracotomyKorea, Republic of
-
Attikon HospitalCompleted
-
Integra LifeSciences CorporationTerminated
-
University Hospital Inselspital, BerneCompletedThoracotomy | SternotomySwitzerland
-
Methodist Health SystemEnrolling by invitation
-
Assistance Publique Hopitaux De MarseilleTerminated
-
University of UlmCompleted
Clinical Trials on bupivacaine-calcitonin-fentanyl
-
Conrad Arnfinn BjørsholCompletedPain, Postoperative | Consumption | Pruritus | Nausea and Vomiting Following Administration of Anaesthetic AgentNorway
-
Augusta UniversityRecruitingLabor Pain | Obstetric PainUnited States
-
Pravara Institute of Medical Sciences UniversityWithdrawnPrimigravida in Labour Pains
-
University of Texas Southwestern Medical CenterCompletedPregnancyUnited States
-
University of AlexandriaCompleted
-
Samuel Lunenfeld Research Institute, Mount Sinai...Terminated
-
Dr. Soliman Fakeeh HospitalCompleted
-
Northwestern UniversityCompleted
-
National Institute for Tuberculosis and Lung Diseases...CompletedPain, Postoperative | Surgery, ThoracicPoland